Sergivell
Brand Name: Sergivell
Generic Name: Bupivacaine Hydrochloride + Dextrose
Active
Registration Number
DRP-7515-01
Dosage Form
Solution For Injection
Issuance Date
June 11, 2023
Expiry Date
June 5, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength5mg/80mg (0.5%/8% W/V)
PackagingBOX OF 1'S AND 5'S
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Local Anesthetic
A
Application
Automatic Renewal
Philippine FDA Classification
Active Ingredients (2)
Complete list of active ingredients in this pharmaceutical product.
Bupivacaine HydrochlorideActive
Monograph: Bupivacaine
DextroseActive
Monograph: Glucose